Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 726

2.

Multimodal Brain Changes in First-Episode Mania: A Voxel-Based Morphometry, Functional Magnetic Resonance Imaging, and Connectivity Study.

Goikolea JM, Dima D, Landín-Romero R, Torres I, DelVecchio G, Valentí M, Amann BL, Bonnín CM, McKenna PJ, Pomarol-Clotet E, Frangou S, Vieta E.

Schizophr Bull. 2018 Apr 17. doi: 10.1093/schbul/sby047. [Epub ahead of print]

PMID:
29672741
3.

Can a Framework Be Established for the Safe Use of Ketamine?

Freedman R, Brown AS, Cannon TD, Druss BG, Earls FJ, Escobar J, Hurd YL, Lewis DA, López-Jaramillo C, Luby J, Mayberg HS, Moffitt TE, Oquendo M, Perlis RH, Pine DS, Rush AJ, Tamminga CA, Tohen M, Vieta E, Wisner KL, Xin Y.

Am J Psychiatry. 2018 Apr 16:appiajp201818030290. doi: 10.1176/appi.ajp.2018.18030290. [Epub ahead of print] No abstract available.

PMID:
29656666
4.

Smoking does not impact social and non-social cognition in patients with first episode psychosis.

Sánchez-Gutiérrez T, García-Portilla MP, Parellada M, Bobes J, Calvo A, Moreno-Izco L, González-Pinto A, Lobo A, de la Serna E, Cabrera B, Torrent C, Roldán L, Sanjuan J, Ibáñez Á, Sánchez-Torres AM, Corripio I, Bernardo M, Cuesta MJ; PEPs group.

Schizophr Res. 2018 Mar 30. pii: S0920-9964(18)30177-4. doi: 10.1016/j.schres.2018.03.025. [Epub ahead of print]

PMID:
29606546
5.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M.

Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14.

PMID:
29536616
6.

Bipolar disorders.

Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, Gao K, Miskowiak KW, Grande I.

Nat Rev Dis Primers. 2018 Mar 8;4:18008. doi: 10.1038/nrdp.2018.8. Review.

PMID:
29516993
7.

Heterogeneity of functional outcomes in patients with bipolar disorder: a cluster-analytic approach.

Solé B, Bonnin CM, Jiménez E, Torrent C, Torres I, Varo C, Valls E, Montejo L, Gómez-Ocaña C, Tomioka Y, Vieta E, Martinez-Aran A, Reinares M.

Acta Psychiatr Scand. 2018 Mar 5. doi: 10.1111/acps.12871. [Epub ahead of print]

PMID:
29508379
8.

Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder.

Tomioka Y, Jiménez E, Salagre E, Arias B, Mitjans M, Ruiz V, Sáiz P, García-Portilla MP, de la Fuente L, Gomes-da-Costa SP, Bobes J, Vieta E, Benabarre A, Grande I.

J Affect Disord. 2018 May;232:229-236. doi: 10.1016/j.jad.2018.02.002. Epub 2018 Feb 13.

PMID:
29499505
9.

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.

Lähteenvuo M, Tanskanen A, Taipale H, Hoti F, Vattulainen P, Vieta E, Tiihonen J.

JAMA Psychiatry. 2018 Apr 1;75(4):347-355. doi: 10.1001/jamapsychiatry.2017.4711.

PMID:
29490359
10.

Effectiveness of a Specialized Brief Intervention for At-risk Drinkers in an Emergency Department: Short-term Results of a Randomized Controlled Trial.

Bruguera P, Barrio P, Oliveras C, Braddick F, Gavotti C, Bruguera C, López-Pelayo H, Miquel L, Segura L, Colom J, Ortega L, Vieta E, Gual A.

Acad Emerg Med. 2018 Feb 8. doi: 10.1111/acem.13384. [Epub ahead of print]

PMID:
29418049
11.

Early Intervention in Bipolar Disorder.

Vieta E, Salagre E, Grande I, Carvalho AF, Fernandes BS, Berk M, Birmaher B, Tohen M, Suppes T.

Am J Psychiatry. 2018 Jan 24:appiajp201717090972. doi: 10.1176/appi.ajp.2017.17090972. [Epub ahead of print]

PMID:
29361850
12.

Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians.

Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, Gallagher P, Lafer B, López-Jaramillo C, Sumiyoshi T, McIntyre RS, Schaffer A, Porter RJ, Purdon S, Torres IJ, Yatham LN, Young AH, Kessing LV, Vieta E.

Bipolar Disord. 2018 Jan 18. doi: 10.1111/bdi.12595. [Epub ahead of print] Review.

PMID:
29345040
13.

Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

Ballesteros A, Sánchez-Torres AM, López-Ilundain JM, Cabrera B, Lobo A, González-Pinto AM, Díaz-Caneja C, Corripio I, Vieta E, de la Serna E, Bobes J, Usall J, Contreras F, Lorente-Omeñaca R, Mezquida G, Bernardo M, Cuesta MJ; PEPs Group.

Psychol Med. 2018 Jan 14:1-10. doi: 10.1017/S0033291717003774. [Epub ahead of print]

PMID:
29331153
14.

Quality indicators in the treatment of patients with depression, bipolar disorder or schizophrenia. Consensus study.

Bernardo M, de Dios C, Pérez V, Ignacio E, Serrano M, Vieta E, Mira JJ, Guilabert M, Roca M.

Rev Psiquiatr Salud Ment. 2018 Jan 6. pii: S1888-9891(17)30141-6. doi: 10.1016/j.rpsm.2017.09.002. [Epub ahead of print] English, Spanish.

15.

Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.

Jiménez-López E, Sánchez-Morla EM, Aparicio AI, López-Villarreal A, Martínez-Vizcaíno V, Rodriguez-Jimenez R, Vieta E, Santos JL.

J Affect Disord. 2018 Mar 15;229:177-185. doi: 10.1016/j.jad.2017.12.094. Epub 2018 Jan 2.

PMID:
29316520
16.

Is recurrence in major depressive disorder related to bipolarity and mixed features? Results from the BRIDGE-II-Mix study.

Mazzarini L, Kotzalidis GD, Piacentino D, Rizzato S, Angst J, Azorin JM, Bowden CL, Mosolov S, Young AH, Vieta E, Girardi P, Perugi G; BRIDGE-II-Mix Study Group.

J Affect Disord. 2018 Mar 15;229:164-170. doi: 10.1016/j.jad.2017.12.062. Epub 2018 Jan 2.

PMID:
29310066
17.

Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients.

Barrio P, Teixidor L, Ortega L, Lligoña A, Rico N, Bedini JL, Vieta E, Gual A.

Drug Alcohol Depend. 2018 Feb 1;183:225-230. doi: 10.1016/j.drugalcdep.2017.11.015. Epub 2017 Dec 27.

PMID:
29291550
18.

Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses.

Belbasis L, Köhler CA, Stefanis N, Stubbs B, van Os J, Vieta E, Seeman MV, Arango C, Carvalho AF, Evangelou E.

Acta Psychiatr Scand. 2018 Feb;137(2):88-97. doi: 10.1111/acps.12847. Epub 2017 Dec 30.

PMID:
29288491
19.

Detection of early psychotic symptoms: Validation of the Spanish version of the "Symptom Onset in Schizophrenia (SOS) inventory".

Mezquida G, Cabrera B, Martínez-Arán A, Vieta E, Bernardo M.

Psychiatry Res. 2018 Mar;261:68-72. doi: 10.1016/j.psychres.2017.12.035. Epub 2017 Dec 14.

PMID:
29287238
20.

Psychometric properties of the well-being index (WHO-5) spanish version in a sample of euthymic patients with bipolar disorder.

Bonnín CM, Yatham LN, Michalak EE, Martínez-Arán A, Dhanoa T, Torres I, Santos-Pascual C, Valls E, Carvalho AF, Sánchez-Moreno J, Valentí M, Grande I, Hidalgo-Mazzei D, Vieta E, Reinares M.

J Affect Disord. 2018 Mar 1;228:153-159. doi: 10.1016/j.jad.2017.12.006. Epub 2017 Dec 6.

PMID:
29248821

Supplemental Content

Loading ...
Support Center